Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KLD Research & Analytics is a pioneer in the field of Environmental, Social, and Governance (ESG) data and analysis for institutional investors. Founded in 1988, the firm is most recognized for creating the Domini 400 Social Index (now the MSCI KLD 400 Social Index), the first benchmark to use ESG criteria for equity selection. The company provides comprehensive research, benchmarks, and compliance tools that allow investors to integrate social and environmental factors into their portfolios. While not a biotechnology or healthcare company itself, KLD's research is a primary source for evaluating the ethical performance, product safety, and corporate governance of major pharmaceutical and life sciences corporations. The firm was acquired by RiskMetrics Group in 2009 and subsequently became part of MSCI.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KLD Research & Analytics.